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Highlights  
 
 Meta-analysis of adolescent abstinent cannabis users (>25 days abstinence) showed 
significantly greater activation in the dorsolateral and ventrolateral prefrontal and 
posterior parietal cortices compared to controls. 
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 Adolescent users showed increased activation in regions involved in executive 
functioning, attentional control and the default mode network compared to non-
using controls.  
 Direct comparison between abstinent cannabis users and current cannabis users 
limited to studies in adolescent users alone revealed no significant group differences 
in brain activation.  
 
 
 
Abstract 
 
Whether the effects of cannabis use on brain function persist or recover following 
abstinence remains unclear. Therefore, using meta-analytic techniques, we examined 
whether functional alterations measured using fMRI persist in cannabis users abstinent for 
over 25 days (or 600 hours) as evidence suggests that the effects on cognitive performance 
no longer persist beyond this period. Systematic literature search identified 20 studies, of 
which, 12 examined current cannabis users (CCU) (361 CCU versus 394 non-cannabis using 
controls (NU)) and 3 examined abstinent cannabis users (ACU) in 5 separate comparisons 
(98 ACU versus 106 NU).  Studies in ACU were carried out in adolescents and suggest 
significantly greater activation in components of the central executive and default mode 
networks in adolescent ACU compared to NU. While this evidence is to be interpreted with 
caution because studies were carried out in overlapping samples, they indicate a pressing 
need for independent confirmation whether certain neurofunctional alterations in AC
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adolescent cannabis users may persist even after cannabis and its metabolites are likely to 
have left their bodies. 
Keywords  
Cannabis, THC, Functional magnetic resonance imaging, Meta-analysis, Abstinence. 
 
 
 
 
Introduction  
Cannabis use has been associated with changes in cognitive task performance (Curran et al., 2002; Jacobus et 
al., 2009; Schoeler et al., 2016a; Schreiner and Dunn, 2012a; Scott et al., 2018; Solowij and Pesa, 2010) and 
altered brain function (Batalla et al., 2013; Tapert et al., 2007) involving various cognitive domains. Impaired 
task performance (Bhattacharyya et al., 2015a; Curran et al., 2002; D'Souza et al., 2004; Hindocha et al., 2015; 
Hindocha et al., 2017; Lawn et al., 2016; Ramaekers et al., 2006) and brain functional alterations (Batalla et al., 
2014; Bhattacharyya et al., 2017; Bhattacharyya et al., 2015b) involving different cognitive domains have also 
been observed during acute intoxication.  Recent meta-analyses employing different analytic approaches have 
shown that persistent long-term use of cannabis is associated with functional alterations in key brain regions 
across different cognitive tasks (Blest-Hopley et al., 2018; Yanes et al., 2018; Yücel et al., 2008).  
 
One of the key issues that can potentially confound the interpretation of current evidence is whether the 
effects of cannabis use on cognition and underlying brain function abstinence persist or recover following a 
period of abstinence. Following abstinence, cognitive performance has been found to improve in cannabis 
users (CU) (Hanson et al., 2010) to the level of controls after longer periods of abstinence (Schulte et al., 2014), 
with cognitive deficits possibly only detectable within the first 25 days of abstinence. Meta-analysis of 
cognitive task performance in continuing CU has shown significant impairment over a wide range of tasks, 
while abstinent users showed no significant difference to controls in any specific or global cognitive domain  
(Schreiner and Dunn, 2012b). In contrast, structural changes in CU have been observed (Batalla et al., 2013), in 
particular decreased volume in the hippocampus (Chye et al., 2018; Cousijn et al., 2012; Matochik et al., 2005), 
that persisted after a prolonged abstinence in some (Ashtari et al., 2011) but not all studies (Koenders et al., 
2017).  
 
However, whether the effects of recreational cannabis use on brain function persist not only beyond the acute 
intoxication stage typically lasting 2-3 hours (Grotenhermen, 2003)(when used by the inhalation route), but 
even after the key metabolites of delta-9-tetrahydrocannabinol (THC) with psychotropic effects have been 
excreted from the body, is less well known. THC and its metabolites(11-hydroxy-9-tertrahydrocannabinol and 
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11-nor-9-carboxy-9-tertrahrdrocannabinol (Sharma et al., 2012) are of particular interest, as it is the main 
psychotropic ingredient in cannabis known to be associated with harmful effects on various cognitive 
domains(Pertwee, 2008). It is worth noting that the half-life of THC in frequent users is 5-13 days (Smith-
Kielland et al., 1999) and THC is detectable in urine for up-to 2-4 weeks(Lowe et al., 2009). Interestingly, the 
upper limit for the period of detection of metabolites in urine is consistent with the period over which 
cognitive deficits are detectable following abstinence (Schreiner and Dunn, 2012b).  
 
We have recently examined the residual effects of recreational cannabis use on brain function in adult and 
adolescent cannabis users by meta-analytically combining the data from 20 published studies employing 
functional MRI techniques (Blest-Hopley et al., 2018). While some of these studies investigated cannabis-using 
participants after a period of abstinence, several others allowed cannabis use up until, as short a period as, 3 
hours prior to scanning. Therefore, interpretation of the results of these studies may be confounded by 
residual acute effects of THC and its metabolites that may still be left in cannabis-using participants as well as 
effects of withdrawal from cannabis. On the other hand, brain functional alteration following a sustained 
period of abstinence has also been investigated, though the results of these studies are less consistent, with 
users showing both increased (Chang et al., 2006; De Bellis et al., 2013; Jacobsen et al., 2004; Schweinsburg et 
al., 2008; Tapert et al., 2007) and decreased (Chang et al., 2006; Schweinsburg et al., 2008) activation 
compared to controls. Studies comparing cannabis users with different periods of abstinence have found 
greater activation in the prefrontal cortex and insula in recently abstinent users compared to users with longer 
(at least 27 days) periods of abstinence, who in turn had greater activation in the precentral gyrus 
(Schweinsburg et al., 2010). Another study that investigated cannabis users at multiple time-points following 
abstinence, reported that 28 days of abstinence resulted in reduced activation difference to controls in some 
regions, but some differences in brain activation persisted (Pillay et al., 2008). Therefore, understanding 
differences in brain activation between currently using (or non-abstinent) and abstinent cannabis users (ACU), 
is of particular interest. However, to our knowledge existing evidence in this regard has not been 
systematically reviewed and summarized using meta-analytic approaches. Hence, we have carried out a meta-
analysis complementary to that previously reported by us (Blest-Hopley et al., 2018) to investigate whether 
altered brain function associated with regular cannabis use persists even after a sustained period of 
abstinence from cannabis. Consistent with our approach previously (Blest-Hopley et al., 2018), we included 
fMRI studies that employed a wide range of cognitive activation paradigms engaging various cognitive 
processes rather than focusing only on task-specific approaches as in other work (Yanes et al., 2018).  Our 
strategy was driven by two key considerations. Firstly, only a limited number of available studies have 
specifically employed comparable activation paradigms limiting our ability to meaningfully investigate the 
question of interest here. More importantly, as we have argued before (Blest-Hopley et al., 2018), the effects 
of cannabis use are unlikely to be limited to only those brain regions that sub-serve cognitive processes 
examined in studies conducted hitherto. Rather they are more likely to be widely distributed, consistent with 
ubiquitous distribution of cannabinoid receptors in the brain (Iversen, 2003). Therefore, we included fMRI 
studies employing a range of cognitive activation paradigms to investigate using a meta-analytic approach AC
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whether brain functional alterations associated with cannabis use persist even after periods of abstinence 
sufficiently long such that cannabis metabolites are no longer detectable in urine.  
 
 
 
 
Methods  
Study Identification 
A systematic search was competed on the 13/12/2017 following the Cochrane Handbook (JPT, 2011) and the 
MOOSE (Stroup et al., 2000) guidelines, using the database PubMed. Two categories of search terms were 
used: 1) cannabis, marijuana, marihuana, THC, tetrahydrocannabinol and 2) imaging, fMRI, functional 
activation, BOLD. Following screening through abstract to meet inclusion criteria.  
Inclusion criteria were:  
 A published peer-reviewed manuscript reported in English 
 A data-based publication 
 Comparison of cannabis users to a non-cannabis using control group (NU) using fMRI 
  Reported whole-brain imaging analysis results and not just region-of-interest analysis results 
  Used a cognitive or emotional activation task with no cannabis-related stimuli 
 
Manuscripts were separated into three categories, based on the type of cannabis-using groups reported. 
Those that reported at least one comparison with current cannabis users (CCU) or with abstinent cannabis 
users (ACU) were included while those that did not report either of the previous comparisons were excluded 
(flow-chart in figure 1; number of manuscripts indicated by ‘N’). CCU were identified as those in whom the 
time interval between the last cannabis smoke and scanning was a maximum of 48hours (so as to avoid peak 
withdrawal symptoms (Budney et al., 2004)) with inclusion criteria requiring at least an average weekly use of 
cannabis or a positive test for THC or its metabolites at urine drug screening. ACU were required to have a 
monitored period of abstinence from cannabis use for at least 600 hours/25 days based on previous evidence 
of upper limit of period of detection of THC metabolites in urine (Schreiner and Dunn, 2012b) and to have 
provided a negative urine test for THC.  
Data Extraction  
Data extraction and data analysis using seed-based d mapping (SDM)(Sdmproject.com, 2017) was conducted 
as outlined previously (Blest-Hopley et al., 2018) and are described here in brief. Significant peak coordinates 
were extracted from included studies along with their t-statistic. In papers reporting z- values or p –values, t- 
statistics were computed using a converter provided with SDM (www.sdmproject.com/utilities 
/?show=statistics). In case of studies where no inferential statistical values were reported, a ‘p’ or ‘n’ was used 
to indicate a positive or negative peak, respectively.  As per protocol for SDM meta-analysis (Radua et al., 
2012) a study-specific text file was created for each study included in the meta-analysis, including the 
coordinates reported, t-value, and the number of participants for each group. In this file, the sign of the t-AC
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statistic was positive or negative, depending on the comparisons of interest. For example, for comparisons 
between CCU and healthy controls, greater activation in CCU compared to healthy controls was indicated as a 
positive t-statistic and vice versa. Similarly, for comparison of ACU with healthy controls, greater activation in 
ACU compared to healthy controls was indicated as a positive t-statistic and vice versa. Following this we 
tested whole-brain differences in activation between CCU and ACU by calculating the difference between both 
groups in each voxel and determining its statistical significance using a randomization test (Radua et al., 2010). 
Information regarding the brain template used to report cluster coordinates (for example, Montreal 
Neurological Institute (MNI) or Talairach) was included in each study-specific file text file created as above. Any 
study that reported no significantly different activation peaks was also included. Each contrast completed 
between CU (CCU or ACU) and controls was extracted and treated as a separate studies, for example if a study 
reported the results of separate encoding and recall conditions in a memory task, these were treated as two 
separate studies, following established protocol (Radua et al., 2012). Each study was then assigned as a study 
with current (CCU) or abstinent (ACU) users.  
 
Data Analysis 
Meta-analysis was carried out using seed based-d-mapping (Sdmproject.com, 2017), using the methods 
previously outlined (Radua et al., 2014) . For voxels that contained a peak coordinate, the unbiased effect-size 
and variance were computed using standard formulae (Hedges and Olkin, 1985), while for all other voxels, the  
effect-size was estimated based on their distance to nearby peaks, using a 20 mm full-width-at-half-maximum 
non-normalized Gaussian kernel (Radua and Mataix-Cols, 2009). For voxels that were assigned a value from 
more than one peak coordinate, an average value was estimated by weighting by the square of the distance to 
each close peak. To reduce bias from a publication reporting numerous closely located peaks, a study 
maximum value was employed. Both the positive and negative activations were assigned to the same map. For 
coordinates with no t-value, a threshold-based imputation of effect-size was carried out by estimating the 
mean effect-size of peaks from studies that did report t-values, separately for each significance threshold. 
Individual effect-size maps were created for each study and a random effects model meta-analytically 
combined the data from each study, by weighting each study with the inverse of the sum of its variance plus 
the between-study variance as obtained by the DerSimonian-Laird estimator (DerSimonian and Laird, 1986). 
This has been shown to be statistically comparable to the restricted maximum likelihood (Viechtbauer, 2005). 
All maps were then included in to a meta-analysis seed-based d map, where a null distribution of the meta-
analytic values was created to test which voxels had studies reporting activation difference around them by 
chance, using monte-carlo randomizations. Due to previous work yielding highly stable results with 20 
randomizations (Radua et al., 2012), we carried out 20 randomisations for each meta-analysis. The co-
ordinates of cluster peaks were then reported using MNI coordinates. 
 
Three initial meta-analyses were completed comparing CCU to NU; comparing ACU to NU and, comparing 
activation in CCU to ACU. Two further meta-analyses were completed, as the ACU group contained only 
adolescent participants, comparing adolescent CCU compared to adolescent NU and comparing adolescent AC
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CCU to the adolescent ACU. Results have been thresholded to ensure voxel threshold = p<0.005, peak height 
threshold: peak SDM-Z < 1, and a cluster-size threshold of clusters ≥ 10 voxels. The co-ordinates of cluster 
peaks were reported using MNI coordinates. 
 
 
 
Assessment of Study heterogeneity and publication bias 
Heterogeneity Q statistic was assessed in terms of a chi-squared distribution after conversion to standard z 
values and reported. Between–study heterogeneity was assessed by comparison of heterogeneity maps. 
Funnel plots were created for each cluster peak and Egger’s test performed in order to asses publication bias 
(Sedgwick and Marston, 2015).  
 
Assessment of Study Quality 
Quality assessment of each study was completed using criteria previously used for fMRI studies (Radua et al., 
2015), which we have reported before (Blest-Hopley et al., 2018).The quality assessment reported here has 
been amended to also include assessment of the extent to which studies accounted for use of substances 
other than cannabis. No studies were excluded from analysis based on this quality assessment. Studies that 
matched groups on use of substances other than cannabis scored 2 points, while those that did not study 
matched groups but instead used statistical methods to control for group differences in use of substances 
other than cannabis scored 1 point. Finally, certain studies controlled for only some substances and were rated 
0.5 and studies that neither matched participant groups based on use of substances other than cannabis, nor 
controlled for them analytically were rated 0. 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
G. Blest-Hopley, V. Giampietro & S. Bhattacharyya 
 
 8 
Results  
Included Studies  
Twenty studies were identified as meeting study inclusion criteria as detailed earlier. Of those, twelve 
manuscripts met inclusion criteria as reporting CCU, with 22 separate comparisons, comparing 361 CCU to 394 
NU (table 1). Three manuscripts were identified as having studied ACU with 5 separate comparisons, 
comparing 98 ACU to 106 NU (table 1). Five manuscripts and one comparison from another manuscript were 
excluded as they had large ranges of abstinence within their cannabis using group (Chang et al., 2006; Heitzeg 
et al., 2015; Jager et al., 2013; Nestor et al., 2010; Nestor et al., 2008; van Hell et al., 2010) or had abstinent 
periods (between 48 and 600 hours) that were not consistent with our pre-defined abstinence criteria for 
inclusion in the ‘abstinent users’ group. Number of studies included for each comparison are indicated by ‘k’ 
and number of participants for each comparison are indicated by ‘n’ henceforth in the text as well as in the 
relevant sections of tables or figures.  
 
Summary of quality assessment of studies included in the present meta-analyses are reported in table 2. 
Although, no studies were excluded from analysis based on this quality assessment, as is evident from the 
summary, studies did not always control for the effect of substances other than cannabis that may have been 
used by study participants. However, it is worth noting that all of the adolescent ACU studies controlled for 
these effects statistically. 
 
All studies qualifying for the ACU group, were carried out in adolescent users. Further meta-analysis comparing 
ACU and CCU, using only adolescent studies was completed. Data from three manuscripts reporting on current 
adolescent users, with four separate comparisons, with 69 CCU and 70 NU were used for comparison with the 
abstinent adolescent user group described above. Results for all meta-analyses are reported in table 3 and 
figure 2.  
 
Adult and adolescent CCU compared to NU  
Meta-analysis of CCU revealed that CCU had increased activation when compared to NU in the medial frontal 
gyrus bilaterally and right insula, extending ipsilaterally to the inferior frontal gyrus. A decrease in activation 
was found in CCU compared to NU in the left cuneus, extending ipsilaterally to the superior, middle, and 
inferior occipital gyri; and in the right precentral gyrus, (k=22; CU n= 361, NU n= 394).  
 
Adolescent ACU compared to NU  
Meta-analysis of adolescent ACU compared to NU revealed that ACU had increased activation in the right 
inferior frontal gyrus; right precuneus, extending ipsilaterally to the superior parietal gyrus; and the right 
middle occipital gyrus, extending ipsilaterally to the superior occipital gyrus and cuneus; the middle frontal 
gyrus extending to the superior frontal gyrus bilaterally and the inferior parietal gyri bilaterally, extending to 
the superior parietal gyrus bilaterally and the right angular gyrus. There were no areas where brain activation 
was significantly decreased in ACU compared to NU (k=5; CU n= 98, NU n= 106) .  
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Adult and adolescent CCU compared to Adolescent ACU  
Meta-analysis comparing CCU including both adult and adolescent studies to adolescent ACU, revealed no 
areas where brain activation was significantly increased in CCU compared to ACU, However, ACU had 
increased activation in the right precuneus, extending ipsilaterally to postcentral and superior parietal gyrI; the 
left lingual gyrus, extending ipsilaterally  to superior and middle occipital gyri; the left middle frontal gyrus 
extending ipsilaterally to superior frontal gyrus; and the inferior parietal lobule bilaterally extending to 
superior parietal gyrus bilaterally and to the right angular gyrus, (CCU: k=22; n=361; ACU: k=5; n=98). 
 
Adolescent CCU compared to NU 
Meta-analysis of adolescent CCU revealed that adolescent CCU had increased activation when compared to 
NU in the right middle frontal gyrus extending ipsilaterally to the inferior frontal gyrus ; and the middle 
occipital gyrus on the right side. There were no areas where brain activation was significantly decreased in 
adolescent CCU compared to (k=4; CU n=69, NU n=70).  
 
Adolescent CCU compared to Adolescent ACU 
Meta-analysis of adolescent CCU compared to adolescent ACU, revealed that there were no areas where brain 
activation was significantly different between adolescent CCU and adolescent ACU NU (CCU: k=4; n=69; ACU: 
k=5; n=98).  
 
Study Heterogeneity  
Funnel plots were created and examined for each cluster from each meta-analysis. Egger’s tests were used 
with no cluster reaching significance, indicating no publication bias (see table 3). SDM-Z scores for each peak 
are reported in table 3, no between-study heterogeneity was seen in the adolescent only ACU vs NU, CCU vs 
NU and ACU vs CCU meta-analyses. In the mixed age group comparison of ACU vs CCU, some heterogeneity 
was seen in the cluster spanning the left superior frontal gyrus.  
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Discussion  
The key comparisons of interest in the present set of analyses relate to the brain activation differences 
between ACU and NU and that between ACU and CCU. Although the ACU versus NU comparison was limited to 
only studies in adolescent cannabis users (as no studies in adult users met our stringent inclusion criteria for 
ACU), we found significantly greater activation in the dorsolateral and ventrolateral prefrontal and posterior 
parietal cortices, which are part of the central executive network and are known to be involved in higher order 
cognitive processes such as attentional control, executive function and working memory (Seeley et al., 2007; 
Sridharan et al., 2008). These findings are similar to those found by a study in adolescent cannabis users 
following an abstinence period of average 5 weeks (Jager et al., 2010). Furthermore, ACU also displayed 
greater activation compared to NU in regions that are part of the default mode network (Buckner et al., 2008) 
such as the cuneus, inferior parietal cortex and angular gyrus as well as the visual cortex. Comparison of ACU 
and CCU across all studies (both adult and adolescent) revealed greater activation in ACU across regions within 
the central executive (dorsolateral prefrontal and posterior parietal cortices) and default mode (inferior 
parietal cortex and precuneus) network as well as lingual and precentral gyri.  However, these differences 
were likely a result of CCU group including both adult and adolescent studies with ACU group including only 
adolescent studies. Direct comparison between ACU and CCU limited to studies in adolescent users alone 
revealed no significant group differences in brain activation. Further comparisons between CCU and NU across 
all eligible studies revealed activation differences in certain brain regions (such as inferior frontal gyrus where 
CCU >NU; and superior, middle and inferior occipital and precentral gyri where CCU<NU) that were broadly 
consistent with results from comparisons between all cannabis users and non-users in our previous meta-
analysis (Blest-Hopley et al., 2018). Although, no comparably consistent patterns emerged from meta-analysis 
of adolescent studies alone, it is worth noting the limited number of studies eligible for inclusion for this 
comparison. Nevertheless, the robustness of our findings was supported by the results of the heterogeneity 
analysis, which showed no between-study heterogeneity in these clusters, as well as the results of the Egger’s 
test, which also showed that none of the reported clusters were significantly affected by publication bias.  
 
Collectively, results of the present meta-analysis clearly suggest that at least in adolescent cannabis users, 
brain functional alterations persist even after periods of abstinence equivalent to around 25 days, by when 
cannabis metabolites are no longer detectable in urine. One cannot be certain on the basis of present analyses 
whether similar functional alterations also persist in adult regular cannabis users after comparable periods of 
abstinence. However, functional alterations in similar brain areas as reported here have also been observed in 
adult occasional cannabis users compared to non-users after prolonged abstinence (Colizzi et al., 2018a; Colizzi 
et al., 2018b). Adolescence is a period of particular vulnerability to the effects of exogenous insults (Andersen, 
2003; Belue et al., 1995; Rice and Barone, 2000; Spear, 2007) such as from use of drugs like cannabis, 
especially in light of progressive change in the density of cannabinoid receptors (Biegon and Kerman, 2001; 
Glass et al., 1997; Mato et al., 2003).  Therefore, results presented here specifically underscore the particular 
vulnerability of the adolescent brain to residual effects of long-term cannabis use even after the drug and its 
metabolites have been fully excreted from the body. AC
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What might underlie these functional differences between abstinent adolescent cannabis users and non-
users? Evidence from two independent studies suggest downregulation of cannabinoid receptor 1 density in 
regular cannabis users (D'Souza et al., 2016; Hirvonen et al., 2012) , which returns to normal levels following 
comparable periods of abstinence (D'Souza et al., 2016; Hirvonen et al., 2012) , with normalisation starting as 
early as following 2 days of abstinence (D'Souza et al., 2016). This may suggest that functional alterations in 
abstinent adolescent cannabis users are unlikely to be related to altered availability of cannabinoid type 1 
receptors. Whether these effects are related to longer-term alterations in glutamatergic (Colizzi et al., 2016) or 
dopaminergic (Sami et al., 2015) neurotransmitter systems also known to be affected by cannabis remains to 
be tested. The cross-sectional nature of the studies included in the present meta-analyses precludes inference 
regarding the precise nature of changes detected, whether they are a cause or consequence of cannabis use. 
Future, studies adopting longitudinal and genetically informed designs are necessary to disentangle causal 
factors from consequential effects(Paul and Bhattacharyya, 2018). Additional limitations need to be carefully 
considered while interpreting these results. Most importantly, this meta-analysis was limited by the number of 
studies available for inclusion. As a result, all studies meeting criteria for the ACU group contained only 
adolescent participants. As no adult studies met our criteria for inclusion to the abstinent group, it is therefore 
difficult to infer that functional alterations in adult users similarly persist following longer periods of 
abstinence. Results of comparisons between CCU and NU are also limited by inclusion of both adult and 
adolescent studies rather than separate analyses, in light of potentially different effects in these age groups 
(Blest-Hopley et al., 2018). However, this does not affect the key results of ACU vs NU and ACU vs CCU in 
adolescent only studies. Furthermore, the three papers investigating adolescent ACU were reported from the 
same research group, with almost complete overlap in the cohorts reported in two of the studies (Schweinsburg 
et al., 2008; Tapert et al., 2007) and around 45% overlap with a much larger cohort reported by Schweinsburg et 
al (Schweinsburg et al., 2011). Therefore, it may be argued that the meta-analysis results are inflated on account 
of non-trivial overlap of the samples investigated. However, it is also worth noting that these 3 studies reported 
on three distinct fMRI activation paradigms (Schweinsburg et al., 2008; Schweinsburg et al., 2011; Tapert et al., 
2007). While this does not address the issue of overlapping samples, it suggests some degree of consistency 
across different cognitive tasks. Nevertheless, this highlights the limited nature of evidence currently available 
regarding longer term effects of cannabis that persist even after its metabolites are no longer detectable in the 
system, and underscore the need for further studies in this area. Another important limitation worth noting 
relates to the effects of withdrawal symptoms confounding comparisons including CCU. Again this is unlikely to 
have affected comparisons between ACU and NU as most withdrawal symptoms typically return to baseline by 
2 weeks (Budney et al., 2004), while participants were abstinent for longer duration (25 days) in studies 
included in the ACU group. While some studies controlled for the potential confounding effects of other 
psychoactive substances (e.g. nicotine, alcohol) either statistically or by including study groups matched for use 
of these substances, others did not. Therefore, we cannot be completely certain that results of our meta-
analyses were not influenced by potential effects of these substances on brain function, when they 
incorporated such studies that did not consider the confounding effect of comorbid exposure to other AC
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substances. Cannabis use parameters, such as age of onset and frequency of use, have been previously found 
to be important in relation to neurological changes (Broyd et al., 2016). A limited number of studies in the 
different sub-groups also precluded systematic examination of the relationship with the extent of previous 
cannabis use. The cannabinoid compositions of cannabis with regard to THC and cannabindiol levels has been 
found produce difference effects (Colizzi and Bhattacharyya, 2017), with high THC cannabis linked to increases 
in extreme psychological outcomes (Di Forti et al., 2009), no study has yet have reported cannabis type. Future 
studies may wish to further explore cannabis composition as a measure, alongside cannabis use parameters. 
Further to this, only certain types of cognitive processes, due to the limited number of studies, may have 
biased the results based on the cognitive processes used. The tasks employed by the adolescent ACU and CCU 
both included go/no go task, but the ACU group studies reported on two memory-related tasks as well, 
whereas the CCU had gambling and finger tapping tasks. While this may have introduced bias (Ganzer et al., 
2016) , it is worth noting that comparison groups (NU) were studied with the same tasks. Nevertheless, we 
cannot rule out this possibility. Methodological heterogeneity between studies, such as cannabis use levels, 
selective reporting of only results that reached statistical significance as is common practice, and studies with 
small sample sizes, are also caveats that are worth considering while interpreting these results.   
 
 Notwithstanding limitations highlighted above, results from the present meta-analyses suggest that certain 
neurofunctional alterations in components of the central executive and default mode networks in adolescent 
cannabis users may persist even after cannabis and its metabolites are likely to have left their bodies. 
However, given the overlap in the samples that support the key conclusions reported here, there is an urgent 
need for independent studies investigating whether brain function in abstinent cannabis users differ 
significantly from non-users following a sustained period of monitored abstinence, both in adolescents as well 
as in adults. Furthermore, whether these persistent brain functional alterations underlie short-term or longer-
term risks of mental, social and behavioural disturbances (Boden et al., 2017; Fergusson et al., 2015; Sami and 
Bhattacharyya, 2018; Schoeler et al., 2018; Schoeler et al., 2016b; Silins et al., 2015; Silins et al., 2014), 
particularly in young people remains to be tested.  
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Figures and Tables 
 
Figure 1: Flow-chart showing the identification, classification and inclusion of papers selected for meta-
analysis.  
*One paper included two studies, one of which was eligible for inclusion, one of which was excluded.
 
 
 
 
  
 
 
 
 
 
 
  
 
	
	
	
	
	
	
	
	
	
	
	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Meta-analysis identification of classification and inclusion of papers.  
*One paper included two studies, one of which was eligible for inclusion, one of which was excluded.  
Current	Cannabis	Users		
Papers	with	average	time	
since	last	cannabis	use	£	48	
hours	
(N=12*)		
Abstinent	Cannabis	Users	
Papers	with	time	since	last	
cannabis	use	³	600	hours	for	all	
participants	
(N=3)		
Excluded	Papers	–	
Large	range	of	abstinence	with	
participants	with	less	time	
since	smoke	for	abstinence	
group		
(N=	4*)		
Abstinence	time	since	last	
cannabis	use	between	£	48	
and	³	600	
(N=1)	
Cannabis	use	of	less	than	
weekly	average	with	no	
positive	THC	required	with	
time	since	last	cannabis	use	£	
48	hours	
	(N=1)	
Total	papers	screened	
(N	=	600)	
Eligible	after	title	review	
(N	=	72)	
	Phase	1	
Papers	excluded	after	title	review	
(N	=	528)	
Eligible	after	abstract	
review	
(N	=	47)	
Phase	2	
Papers	excluded	after	abstract	
review	(N	=	25)	
Eligible	after	full	article	
review	
(N	=	21)	
Phase	3	
Papers	excluded	after	full	article	
review	
(N	=	26)	
	
Data	extracted	and	papers	
used	in	meta-analysis	
(N=20)	
(adult	studies	=	13	
adolescence	studies	=	7)		
Excluded	owing	to	lack	of	
information	required	for	
data	extraction		
(N=	1)	
Papers	identified	through	database	search	
(N	=	598)	
	
Additional	papers	identified	through	Bibliography	search	
(N=	2)	
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Figure 2. Maps of statistically significant differences in activation (Voxel threshold = p<0.005, peak height threshold: peak SDM-Z < 1, clusters ≥ 10). Axial brain slice position 
shown on a sagittal view bottom right, with slices arranged from left to right in the different panels showing brain slices in ascending order from bottom to top.  
A - Activation of current CU compared to non-using control subjects, increased activation in CU shown in red, decreased activation in CU shown in blue (k=22; CU n= 361, 
NU n= 394) 
B - Activation of adolescent abstinent CU compared to non-using controls, increased activation in CU shown in red (k=5; CU n= 98, NU n= 106) 
C - Activation of adolescent abstinent CU compared to current adult and adolescent CU, increased activation in abstinent users shown in red (CCU: k=22, n=361; ACU: k=5, 
n=98) 
D - Adolescent current CU compered to non-using controls, increased activation in CU shown in red (k=4; CU n=69, NU n=70). 
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Table 1 : Studies included in meta-analysis  
Current 
Cannabis 
User 
Studies  
fMRI 
activation 
task 
CU 
M/
F 
NU  
M/F 
Age of 
CU 
(years) 
Age of 
NU 
(years) 
 
Quantity 
of 
cannabis 
used by 
CU 
Time 
betwee
n scan 
and last 
smoke 
* 
Age of 
onset of 
cannabi
s use 
for CU 
(years) 
Average 
years of 
cannabi
s use by 
CU 
Task 
condition 
Results 
whole 
brain 
analysis 
Task 
Performanc
e results 
Number of 
task 
compariso
ns 
Tesl
a 
Abdullaev 
et al., 
2010 
 
Attention 
Network 
Task 
10/
4 
10/4 19.5 
(0.8) 
(SD) 
19.7 
(1.4) 
(SD) 
71-196 
days per 
year 
48 12-16 N/A Executive 
task; 
Alerting 
task; 
Orienting 
task. 
CU>NU R-
LPFC, 
suppleme
ntary 
motor 
cortex, 
Lateral 
parietal 
cortex; No 
difference 
for 
alerting & 
orientatio
n task. 
Longer 
reaction 
time for CU. 
More errors 
made for 
executive 
task. 
3 3T 
 Use 
Generatio
n Task 
5/2 5/2 19.6 
(0.9) 
 
20 
(0.2) 
(SD) 
71-196 
days per 
year 
48 12-16 N/A Generatin
g nouns 
versus 
reading 
nouns; 
difficult 
words 
versus 
easy 
words. 
CU>NU R-
VPFC 
NU>CU Bi 
-ACG to L-
PFC, L- 
TPC; 
CU>NU R - 
ACC, R 
FOC, L 
frontal 
pole & L 
precuneus
. 
N/A 2 3T 
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Smith et 
al., 2011 
 
Go/NoGo 
Task 
6/4 9/5 19-21 19-21 > 1 joints 
per week 
3 
 
N/A 4.55 
years 
Press all 
but X; 
Press X 
No 
significant 
difference
s in both 
tasks after 
including 
covariates
. 
No 
Significant 
difference 
2 1.5T 
Chang et 
al, 2006 
 
Visual- 
Attention 
Task 
9/3 11/8 27.91 
6 3.13 
(SEM) 
30.57 
6 1.83 
(SEM) 
≥5 days 
per week 
4 9–20 
 
36–448 
months 
 
Visual 
attention 
CU>NU 
small 
clusters of 
L 
precuneus
, L-LG & L 
limbic 
uncus. 
NU>CU R-
FC, Bi- 
dorsal 
parietal 
and R 
cerebella. 
No 
Significant 
difference 
1 4T 
Cousijn et 
al., 2012 
 
Iowa 
Gambling 
Task 
21/
11 
26/1
5 
21.4 
(2.3) 
(SD) 
22.2 
(2.4) 
(SD) 
> 10 days 
per 
month 
38.4 N/A 2.5 (1.9) 
(SD) 
Win>Loss; 
Loss>Win 
CU>NU R-
OFC, R 
insula, L-
STG; No 
activation 
difference
. 
No 
Significant 
difference 
2 3T 
Gruber, 
Rogowska 
and 
Yurgelun-
Todd, 
2009 
 
Facial 
effect task 
14/
1 
14/1 25 
(±8.8) 
 
26 
(±9.0) 
 
4-7 days 
per week 
12  14.9 
(±2.50) 
 
N/A Viewing 
Angry; 
Viewing 
Happy 
CU>NU R-
IFG, R-
precuneus
, R-
paracetral 
lobe, L-
SFG, 
No 
Performanc
e data 
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cerebellar, 
R-MiTG, 
NU>CU L-
SPL, 
interhemis
pheric 
precuneus
, L- CG ; 
CU>NU 
cerebella, 
NU>CU L -
STG & 
sub.lobula
r space. 
Heitzeg et 
al., 2015 
 
Emotional 
arousal 
word task 
12/
8 
14/6 19.84 
(1.45) 
(SD) 
20.51 
(1.26) 
(SD) 
>100 
time 
(average 
618.12) 
48  N/A 13.4 
(2.7)  
(SD) 
Negative 
words; 
Positive 
words. 
NU>CU R- 
MiFG, R- 
DLSFG, R- 
MiTG, R-
STG, R 
calcarine 
fissure, R- 
L, insula 
CU>NU R 
Dorsolater
al SFG, 
NU>CU R-
IPL. 
No 
Significant 
difference 
2 3T 
King et al., 
2011 
Checker-
board task 
16/
14 
16/1
4 
M = 21 
F = 
22.5 
M= 23 
F= 24.5 
6-7 days 
per week 
12  M= 14.5 
F= 16 
(years) 
 
M= 78 
F= 63 
(months
) 
2HZ 
frequency
; 4HZ 
frequency 
CU>NU 
SFG, 
NU>CU LG 
& cuneus; 
L- 
postcentr
al gyrus, 
Bi- MiFG, 
R-SPG, R- 
None Taken 2 3T AC
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frontal 
pole, 
NU>CU R- 
postcentr
al gyrus, 
R- 
precentral 
gyrus & L- 
LG. 
Kanayama 
et al., 
2004 
Spacial 
working 
memory 
Task 
10/
2 
6/4 37.9 
(7.4) 
(SD) 
27.8 
(7.9) 
(SD) 
5100-
54000 
life time 
use 
21 N/A >5000 
lifetime 
use 
Short- 
delay task 
minus 
perceptio
n task. 
CU>NU R-
SFG, L-
MiFG, IFG, 
R-STG, Bi. 
ACG. R. 
precentral 
gyrus, Bi -
caudate & 
R-
putamen. 
NU>CU Bi 
-MiFC. 
No 
Significant 
difference 
1 1.5T 
Wesley, 
Hanlon 
and 
Porrino, 
2011 
Iowa 
Gambling 
Task 
9/7 6/10 26.4 
(3.6) 
(SD) 
26.6 
(6.1) 
(SD) 
Mean 
29.4 days 
per 
month 
12 16.3 
(2.1) 
(SD) 
9.6 (4.1) 
(SD) 
Win; Lose No 
difference 
in Win; 
NU>CU Bi. 
MFG, R 
ACC, R-
Precuneus 
& R- 
SPL, L 
declive. 
More loss 
events for 
CU 
2 1.5T 
Adolescen
t Current 
Cannabis 
Users 
Task CU 
M/
F 
NU 
M/F 
Age of 
CU 
(years) 
Age of 
NU 
(years) 
 
Quantity 
of 
cannabis 
used by 
CU 
Time 
betwee
n scan 
and last 
Age of 
onset of 
cannabi
s use 
Average 
years of 
cannabi
s use by 
CU 
Trials Results 
whole 
brain 
analysis 
Task 
Performanc
e results 
Number of 
task 
compariso
ns 
Tesl
a 
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smoke 
* 
for CU 
(years) 
Acheson 
et al., 
2015 
Win/Lose 
Gambling 
Task 
11/
3 
11/3 17.3 
(1.3)  
(SEM) 
17.6 
(1.0)  
(SEM) 
>5 uses 
per week 
12 N/A N/A Win ; Loss CU>NU Bi- 
MiFG, 
caudate 
claustrum; 
CU>NU R- 
MiFG, R- 
PCC R- 
ACC, L-
Insula, Bi. 
claustrum 
Bi- 
declive. 
Not 
Reported 
2 3T 
Behan et 
al., 2014 
Go/NoGo 
Task 
16/
1 
17/1 16.5 
(0.2)  
(SEM) 
16.1 
(0.4)  
(SEM) 
42.9 
mean 
joints per 
week 
12 13 (0.2)  
(SEM) 
 
N/A Successful 
inhibition 
NU>CU Bi. 
white 
matter 
adjacent 
to ACC. 
CU 
significantly 
worse at 
inhibition 
task. 
1 3T 
Lopez-
Larson et 
al., 2012 
Finger 
Tapping 
22/
12 
17/7 18.2 
(0.7)  
(SD) 
18.0 
(1.9)  
(SD) 
Mean 
use of 
10.3 
joints per 
week 
24 15.3 
(1.4)  
(SD) 
N/A Finger 
taping 
NU>CU R- 
CG 
Not 
Reported 
1 3T 
Abstinent 
Cannabis 
User 
Studies 
Task CU 
M/
F 
NU  
M/F 
Age of 
CU 
(years) 
Age of 
NU 
(years) 
 
Quantity 
of 
cannabis 
used by 
CU 
Time 
betwee
n scan 
and last 
smoke 
* 
Age of 
onset of 
cannabi
s use 
for CU 
(years) 
Average 
years of 
cannabi
s use by 
CU 
Trials Results 
whole 
brain 
analysis 
Task 
Performanc
e results 
Number of 
task 
compariso
ns 
Tesl
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Schweins-
burg et al., 
2011 
Verbal 
Encoding 
Task 
27/
9 
29/9 18.1 
(0.9) 
18.0 
(1.0)   
(SD) 
17.6 
(0.8)  
18.1 
(0.7)  
(SD) 
480.7 
(277.2 
SD) life 
time use  
 
600 14.5 
(2.5)  
14.9 
(3.4)  
(SD) 
N/A Novel 
encoding 
No 
significant 
difference
. 
No 
Significant 
Difference 
1 3T 
Schweins-
burg et al., 
2008 
Spacial 
working 
memory 
Task 
11/
4 
12/5 18.1 
(0.7)  
(SD) 
17.9 
(1.0)  
(SD) 
480.7 
(277.2 
SD) life 
time use 
672 N/A 4.0 (1.6)  
(SD) 
SWM> 
Viligance; 
Viligance> 
SWM. 
CU>NU R- 
SPL  
NU>CU R- 
DLPFC; 
CU>NU R - 
Inferior 
cuneus. 
No 
Significant 
Difference 
2 1.5T 
Tapert, et 
al, 2007 
Go/NoGo 
Task 
12/
4 
12/5 18.1 
(0.7)  
(SD) 
17.9 
(1.0)  
(SD) 
>60 
times 
672 14.0 
(1.6)  
 
N/A Inhibition; 
Go 
CU>NU Bi- 
SFG, Bi- 
MiFG, R-
Insula, L- 
MPFC, Bi- 
PPC, R- 
LG, 
CU>NU R-
IFG, R- 
insula, R-
SFG, R-
SPL, R-IPL, 
R medial 
precuneus
.  
No 
Significant 
Difference 
2 1.5T 
AC
CE
PT
ED
 M
AN
US
CR
IPT
G. Blest-Hopley, V. Giampietro & S. Bhattacharyya 
 
 28 
*Time between scan and last smoke reported here as the mean or median estimate (number of hours) 
reported in the manuscript, or based on the inclusion/exclusion criterion related to minimum period of 
abstinence reported in the manuscript. 
CU = Cannabis users NU = Non-using controls, R = Right, L = Left, Bi = Bilateral, LPFC = Lateral Prefrontal Cortex, 
VPFC = Ventrolateral Prefrontal Cortex, DLPFC = Dorsolateral Prefrontal Cortex, MPFC = Medial Prefrontal 
Cortex, PFC = Prefrontal Cortex, OFC = Orbitofrontal Cortex, FC = Frontal Cortex, MFG = Medial Frontal Cortex, 
MiFG = Middle Frontal Gyrus, SFG = Superior Frontal Gyrus, DLSFG = Dorsolateral Superior Frontal Gyrus, FOC 
= Frontal Orbital Cortex, IFG = Inferior Frontal Gyrus, PPC = Posterior Parietal Cortex, IPL = Inferior Parietal 
Lobe, TPC = Temporo-Parietal Cortex, SPL = Superior Parietal Lobe, SPG = Superior Parietal Gyrus, MTG = 
Medial Temporal Gyrus, MiTG = Middle Temporal Gyrus, STG = Superior Temporal Gyrus, LG = Lingual Gyrus, 
CG = Cingulate Gyrus, ACC = Anterior Cingulate Cortex, ACG = Anterior Cingulate Gyrus  
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Table 2 – Quality assessment  
Study   
Sample 
size 
Inclusion 
criteria 
Exclusion 
criteria  
Control for 
other 
substance 
use  
Match for 
age/sex/ 
handedness/ 
education 
Control for 
motion 
artefacts 
Co-
registration 
with 
anatomical 
image 
Software 
and 
statistical 
test applied 
Correction 
for multiple 
testing 
Sum of the 
scores & 
category 
Current Cannabis Users 
Abdullaev et 
al., 2010 
1 1 1 2 1 2 2 2 2 14 
Smith et al., 
2011 
0.5 1 1 1 2 2 2 1 2 13 
Chang et al, 
2006 
1 2 2 0 2 2 2 2 2 15 
Cousijn et al., 
2012 
2 2 2 1 2 2 2 2 2 17 
Gruber, 
Rogowska 
and 
Yurgelun-
Todd, 2009 
1 2 1 1 2 2 2 2 0 13 
Heitzeg et al., 
2015 
1 2 2 2 1 2 2 2 2 16 
King et al., 
2011 
2 2 2 0.5 1 2 2 2 2 15.5 
Kanayama et 
al., 2004 
0.5 1 1 2 1 2 2 2 0 11.5 
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Wesley, 
Hanlon and 
Porrino, 2011 
1 1 2 0.5 2 2 2 2 2 14.5 
Adolescent Current Cannabis Users 
Acheson et 
al., 2015 
1 2 1 0 1 2 2 2 2 13 
Behan et al., 
2014 
1 1 1 0 2 2 2 2 2 13 
Jager et al., 
2013 
2 2 1 1 1 0 2 1 2 12 
Adolescent Abstinent Cannabis User Studies 
Schweinsburg 
et al., 2011 
2 2 1 1 1 2 2 2 2 15 
Schweinsburg 
et al., 2008 
1 1 1 1 1 2 2 2 2 13 
Tapert, 
Schweinsburg 
and Brown, 
2008 
1 1 1 1 2 2 2 2 2 14 
Rating criteria: Sample size: n1<12,n2<12: 0 point; n1<12,n2=12-20: 0.5 point; n1<12,n2>20: 1 point; n1=12-20,n2<12: 0.5 point; n1=12-20,n2=12-20: 1 point; n1=12-
20,n2>20: 1.5 point; n1>20,n2<12: 1 point; n1>20,n2=12-20: 1.5 point; n1>20,n2>20: 2 point. Inclusion criteria: 0 (not reported), 1 (partly reported), 2 (reported). Exclusion 
criteria 0 (not reported), 1 (only one reported), 2 (reported). Control for other substance use: Groups not matched for other substance use and not statistically controlled 
for 0 points; groups not matched for other substance use and only some substances statistically controlled for 0.5 points; groups not matched for other substance use, but 
statistically controlled for 1 point; groups matched for other substance use 2 points. Matched for age/sex/handedness/education: 0 (for no parameter), 1 (partly), 2 (for all 
parameters). Control for motion artefacts: 0 (not performed), 2 (performed). Co-registration with anatomical image: 0 (not performed), 2 (performed) Software and 
statistical test applied: 0 (not reported), 1 (partly reported), 2 (reported). 
Correction for multiple testing: 0 (not corrected), 2 (corrected). 
Commented [MOU1]: What is this? 
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Table 3: Results from meta-analyses 
x y z Voxels p SDM-Z Egger’s test p 
value  
Brain regions 
Meta-analysis: CCU vs NU (k=22; CU n= 361, NU n= 394) 
CCU > NU 
-4 -4 62 177 0.001409173 1.617 0.872 Left medial frontal gyrus extending 
bilaterally 
38 18 2 340 0.000125647
 
0.000464737
0 
           1.942 0.406 Right insula extending to ipsilateral 
inferior frontal gyrus  
CCU < NU 
-10 -98 -8 684 0.000094950 -1.664 0.302 Left cuneus extending to ipsilateral 
superior, middle, and inferior occipital 
gyri 
30 -18 56 165 0.001311898 -1.288 0.595 Right precentral gyrus  
      
Meta-analysis: ACU vs NU (only adolescent studies) (k=5; CU n= 98, NU n= 106) 
ACU > NU 
46 -46 50 669 0.00013572 1.554 0.418 Right inferior parietal lobule extending  
to ipsilateral superior parietal and 
angular gyri  
38 52 10 142 0.001023412 1.162 0.851 Right middle frontal gyrus extending to 
ipsilateral superior frontal gyrus  
26 -92 6 86 0.00138104 1.121 0.652 Right middle occipital gyrus extending 
to ipsilateral superior occipital gyrus 
and cuneus 
-34 58 -6 67 0.00138104 1.121 0.724 Left middle frontal gyrus extending to 
ipsilateral superior frontal gyrus  
8 -60 68 56 0.000980318 1.170 0.816 Right precuneus extending to 
ipsilateral superior parietal gyrus 
-42 -52 58 30 0.00138104 1.121 0.577 Left inferior parietal lobule extending 
to ipsilateral superior parietal gyrus 
60 16 8 19 0.001511097 1.110 0.132 Right inferior frontal gyrus  
Meta-analysis: CCU vs ACU (adult as well as adolescent studies) (CCU: k=22, n=361; ACU: k=5, n=98) 
ACU > CCU  
46 -48 50 390 0.000501096 1.244 0.443 Right inferior parietal lobule extending 
to ipsilateral inferior parietal, superior 
parietal and angular gyri 
-10 -98 -8 263 0.000559688 1.228 0.320 Left lingual gyrus extending to 
ipsilateral middle and superior 
occipital gyri 
6 -60 68 100 0.000584483 1.220 0.898 Precuneus extending to ipsilateral 
postcentral and superior parietal gyri  
-34 58 -4 53 0.002155423 1.019 0.753 Left middle frontal gyrus extending to 
ipsilateral superior frontal gyrus 
-38 -52 60 46 0.001968861 1.033 0.753 Left inferior parietal lobule extending 
to ipsilateral superior parietal gyrus 
Meta-analysis: Adolescent CCU vs NU (k=4; CU n=69, NU n=70) 
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44 28 34 220 0.000734389 1.061 0.238 Right middle frontal gyrus extending to 
ipsilateral inferior frontal gyrus. 
40 -86 20 71 0.000344992 1.211 0.678 Right middle occipital gyrus 
CCU: Current cannabis users; ACU: Abstinent cannabis users; NU: Non-user healthy controls 
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